Aleena Banerji MD

Allergy & Immunology•Boston, MA

Associate Professor of Medicine, Harvard Medical School; Clinical Director, Allergy and Immunology at Massachusetts General Hospital

Join to View Full Profile

100 Blossom StreetCox 201Boston, MA 02114
Phone+1 617-726-3850
Fax+1 617-724-0239

Education & Training

Mass General Brigham/Massachusetts General HospitalFellowship, Allergy and Immunology, 2003 - 2005
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1999 - 2002
Northwestern University The Feinberg School of MedicineClass of 1999

Certifications & Licensure

MA State Medical License 2002 - 2027
ME State Medical License 2021 - 2023
NH State Medical License 2021 - 2023
RI State Medical License 2021 - 2022
OH State Medical License 1999 - 2002
American Board of Allergy and Immunology Allergy & Immunology

Awards, Honors, & Recognition

Boston, Top Doctor
Most Compassionate Doctor American Registry

Clinical Trials

Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE Start of enrollment: 2011 Dec 01
Completed
Phase 4
The Metabolomics of Anaphylaxis Start of enrollment: 2012 Mar 01
Withdrawn
The Metabolomics of Anaphylaxis to Immunotherapy Start of enrollment: 2012 Apr 01
Withdrawn
Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema Start of enrollment: 2013 Dec 02
Completed
Phase 3
Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment Start of enrollment: 2014 Jan 01
Terminated
Phase 4
A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Participants Start of enrollment: 2014 May 14
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

Lanadelumab's impact on hereditary angioedema control and quality of life across disease activity subgroups: Real-world evidence.
Andrea Zanichelli, Walter A Wuillemin, Emel Aygören-Pürsün, Aleena Banerji, Paula J Busse
Annals of Allergy, Asthma & Immunology. 2025-11-01
Population-scale Analysis Reveals Germline Loss of SERPING1 (C1-Inhibitor) is a Polyphenotypic Thrombotic Disorder.
Alfonso Rodriguez Espada, Amelia Haj, Sean Joseph Jurgens, Harish Eswaran, Linda Sundler Björkman
Blood Advances. 2025-09-30
The drug allergy history tool (DAHT): Validation of a patient-reported survey instrument.
Kimberly G Blumenthal, Daniel A Gundersen, Liam R Smith, Brett Nava-Coulter, Andrew King
The Journal of Allergy and Clinical Immunology. 2025-09-01

Journal Articles

Effect of Lanadelumab Compared with Placebo on Prevention of Hereditary Angioedema Attacks
Jonathan A Bernstein, Lawrence B Schwartz, Andrew M Smith, H James Wedner, Daniel Soteres, Timothy Craig, Douglas T Johnston, Aleena Banerji, Paula J Busse, William R ..., JAMA
Original Article Identification of Inpatient Allergic Drug Reactions Using ICD-9-CM Codes
Kimberly G Blumenthal, Aleena Banerji, Rebecca R Saff, ScienceDirect

Other

Patient-Reported Burden of Hereditary Angioedema: Findings from a US Patient Survey
Aleena Banerji, MD, Annals of Allergy, Asthma & Immunology
https://www.doximity.com/articles/ccd32daf-91ac-411b-ae17-38cbe01a70ea
UpToDate, Wolters Kluwer Health - 2012-12-12

Authored Content

Patient-Reported Burden of Hereditary Angioedema: Findings from a US Patient SurveyMarch 2020

Press Mentions

Massachusetts Homeopathic Seasonal Allergy Relief: Natural Treatment AnnouncedAugust 23rd, 2024
European Allergy Task Force Provides Clinical Guidance on ChemotherapyFebruary 4th, 2022
Polyethylene Glycol Linked to Rare Allergic Reactions Seen with mRNA COVID-19 VaccinesSeptember 28th, 2021
Join now to see all

Professional Memberships